BOSTON--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer, today announced that the company will present at the following upcoming investor conferences:
• 18th Annual BIO CEO & Investor Conference on Tuesday, February 9 at 8:00 a.m. ET at the Waldorf Astoria Hotel in New York City
• Leerink Partners 5th Annual Global Healthcare Conference on Wednesday, February 10 at 11:30 a.m. ET at the Waldorf Astoria Hotel in New York City
